Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology

作者：William John Gradishar, Benjamin O. Anderson, Ronald Balassanian, Sarah L. Blair, Harold J. Burstein, Amy E. Cyr, ANTHONY D. ELIAS, William Blair Farrar, Andres Forero, Sharon Hermes Giordano, Matthew Philip Goetz, Lori J. Goldstein, Steven Jay Isakoff, Janice A. Lyons, P. Kelly Marcom, Ingrid A. Mayer, Beryl L. McCormick, Meena S. Moran, Ruth M O'Regan, Sameer A. Patel, Lori J. Pierce, Elizabeth C. Reed, Kilian Elizabeth Salerno, Lee Steven Schwartzberg, Amy M. Sitapati, Karen Lisa Smith, Mary Lou Smith, Hatem Hussein Soliman, George Somlo, Melinda L. Telli, John Headley Ward, Rashmi Kumar, Dorothy Agnes Shead · 发表于：Journal of the National Comprehensive Cancer Network · 年份：2018 · DOI：10.6004/jnccn.2018.0012 · 被引用次数：1621 · 研究领域：Breast Cancer Treatment Studies、Breast Lesions and Carcinomas、HER2/EGFR in Cancer Research

Ductal carcinoma in situ (DCIS) of the breast represents a heterogeneous group of neoplastic lesions in the breast ducts. The goal for management of DCIS is to prevent the development of invasive breast cancer. This manuscript focuses on the NCCN Guidelines Panel recommendations for the workup, primary treatment, risk reduction strategies, and surveillance specific to DCIS.